Sopharma reported 45% YoY surge in Oct’23 unconsolidated sales, consisting of 42% YoY growth of exports and 53% YoY growth of domestic sales. 10-mo sales increased by 18% YoY due to 27% YoY growth of exports and 5% increase of domestic sales.